Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2018
Source ID
10.1016/j.ymthe.2017.12.006

Entities

People

  • Dmitriy Zamarin

Organizations

  • Memorial Sloan Kettering Cancer Center
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech